Skip to Content

CALCIMAX SYRUP

Active substance(s): ASCORBIC ACID / CALCIUM CHLORIDE / CALCIUM LAEVULINATE / CALCIUM PANTOTHENATE / NICOTINAMIDE / PYRIDOXINE HYDROCHLORIDE / RIBOFLAVINE / THIAMINE HYDROCHLORIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
Calcimax Syrup
Please read this leaflet carefully before using this
medicine. If you have any questions or are not sure
about anything, ask your doctor or pharmacist.
Calcimax Syrup has the following active ingredients
in each 5ml:
Calcium Levulinate
350.00 mg
Calcium Chloride Dihydrate BP 120.00 mg
Nicotinamide BP
2.00 mg
Riboflavine BP
0.125 mg
Thiamine Hydrochloride BP
0.50 mg
Pyridoxine Hydrochloride BP
0.125 mg
Ascorbic Acid BP
5.00 mg
Calcium Pantothenate BP
0.125 mg
In addition the syrup also contains the following nonactive ingredients: Disodium Edetate, Sucrose,
Glycine, Sodium Saccharin, Nipasept, Nipabutyl,
Propylene Glycol, Glycerin, Soluble Orange Oil,
Essence Morella Cherry, Burnt Sugar, Hydrochloric
Acid, Purified Water
Calcimax syrup is available in bottles of 150ml.
Calcimax is a dietary supplement of Calcium and
Vitamins B and C.
The product licence holder is
Wallace Manufacturing Chemists Ltd,
Wallace House, 51-53 Stert Street
Abingdon, Oxfordshire OX14 3JF, United Kingdom
Product Licence number: PL 00400/5007R
The product is manufactured for
Wallace Manufacturing Chemists Ltd by
Thorpe Laboratories Ltd,
Enterprise Road, Mablethorpe,
Lincolnshire LN12 1NB
The product is intended as a supplement of Calcium
and Vitamins B and C during periods of dietary need.
It is not intended to treat clinical deficiencies.
Do not take Calcimax Syrup if any of the following
applies to you:







You suffer from raised blood calcium levels
You have pronounced levels of calcium in your
urine
You have taken an overdose of Vitamin D
You suffer from tumours which remove calcium
from the body
You have severe kidney failure
You have kidney stones

You should seek medical advice before taking
Calcimax Syrup if you have any kidney problems.
The syrup contains sucrose and this may adversely
affect dental hygiene or control of diabetes. Calcimax
has propylene glycol as a preservative and
hypersensitivity reactions may occur in susceptible
individuals.

Calcimax Syrup may react with other foods or
medicines you are taking.

It may reduce the efficacy of Tetracyclines

It may interfere with the actions of L-dopa

If you also take thiazides (used to increase urine
flow) there is the risk of elevated levels of
calcium in the blood

Unless advised by your doctor it is advisable to
avoid other foods or medicines with high doses
of Vitamin D

It may cause increased side effects from
digoxin.
Calcimax is considered safe for use during
pregnancy and in nursing mothers.
Recommended Dose and Dosage Schedules
Adults and Elderly: Four 5ml spoonfuls to be taken
twice or more times per day as directed by a doctor
Children: One to Two 5ml spoonfuls to be given three
times per day according to age or as directed by a
doctor
Overdose
Overdose is unlikely with Calcimax Syrup. If you do
feel concerned that you have taken an overdose, or
that you have combined Calcimax with another food
or medicine such as to cause an overdose of one of
the active ingredients, then seek medical advice
immediately. Take the products and any information
leaflets with you provided it does not undue delay.

If you have missed a dose then simply resume
treatment when the next dose falls due.
As with all medicines Calcimax Syrup may cause
adverse effects. These can include mild stomach
upsets. It is unlikely that Calcimax Syrup would
cause sufficiently high levels of calcium in the blood
to cause concern, however the following symptoms
are possible indicators of very high blood calcium
levels:









nausea
vomiting
anorexia
constipation
abdominal pain
thirst
increased production of urine
muscle weakness

If you exhibit any of the above symptoms or other
symptoms not listed which you feel may be cause by
taking Calcimax Syrup it is wise to seek the advice of
your doctor or pharmacist.
Do not use after the date marked on the label.
Store in a cool place.
Date leaflet last revised: 17 April 2009

Wallace

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide